Morin, a novel liver X receptor α/β dual antagonist, has potent therapeutic efficacy for nonalcoholic fatty liver diseases

Ming Gu(Shanghai University of Traditional Chinese Medicine), Cheng Huang(Shanghai University of Traditional Chinese Medicine)
British Journal of Pharmacology
June 24, 2017
Cited by 41


Related Papers